The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
22hon MSN
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...
“The FTC’s administrative action seeks to put an end to the Big Three PBMs’ exploitative conduct and marks an important step ...
The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The suit accuses the "Big Three" of steering diabetes patients toward high-priced insulin to benefit their bottom lines ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback